Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eleven Biotherapeutics Inc (NASDAQ:EBIO)

2.87
Delayed Data
As of 3:59pm ET
 -0.23 / -7.42%
Today’s Change
0.25
Today|||52-Week Range
5.97
-4.65%
Year-to-Date

Today’s Trading

Previous close3.10
Today’s open3.05
Day’s range2.80 - 3.19
Volume1,281,666
Average volume (3 months)2,881,920
Market cap$62.5M
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+25.74%
Earnings growth (this year)+41.41%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-55.86%
P/E ratioNM
Price/Sales57.75
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc+0.02+1.18%
XOMAXOMA Corp-0.02-4.60%
CRMECardiome Pharma Corp-0.05-1.60%
AVIRAviragen Therapeutic...+0.20+12.05%
Data as of 3:59pm ET, 09/26/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$990.0K
Annual profit (last year)-$33.5M
Net profit margin-3,378.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen Allen Hurly
Chief Financial Officer
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs